Wednesday, October 29, 2014 10:57:30 AM
Plandai Biotechnology, Inc. Receives Approval to Grow Cannabis for Medical Research From Uruguay's Ministry of Public HealthFont size: A | A | A
9:08 AM ET 10/29/14 | Marketwired
PlandaÃ? Biotechnology, Inc. (OTCQB: PLPL) ("PlandaÃ?" or "the Company"), a developer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today announced that Uruguay's Ministry of Public Health has approved an academic collaboration between PlandaÃ? and the Group of Medicinal Chemistry from the School of Science at the University of the Republic ("University") in Montevideo, Uruguay. The approval, issued in September 2014, allows PlandaÃ? to grow cannabis in conjunction with the University, for medical research, which will be undertaken by students and scientists from the School of Science at the University.
PlandaÃ? Biotechnology - Uruguay, SA, a wholly owned subsidiary of PlandaÃ? Biotechnology, is currently the only company given authorization to grow cannabis and conduct medical research in Uruguay. Published research indicates that PlandaÃ?'s proprietary extraction process should render the complete cannabinoid complex from the live plant while retaining the acid forms of THC, which are devoid of psychotropic effects. The result should be a highly bioavailable extract that retains all of the potential medical benefits of cannabis without the psychoactive properties. PlandaÃ? intends to establish a pharmaceutical platform in once the initial scientific investigations have been successfully completed.
This research project is scheduled to take place over a 3-year period beginning early 2015. The first phase of the project will establish the infrastructure and protocols for growing the cannabis in a controlled environment to ensure genetic purity and chemical consistency. A team of academics at the University will then collaborate with PlandaÃ?'s scientists to test the cannabinoid complex for potential benefit for treating neuron disorders, cancers and concussion injuries through animal testing. However, before the Company can conduct human clinical trials, prior approval from Uruguay's Ethics Committee and Medicine Council will be required.
The University of the Republic is a State institution founded in 1849. With several campuses throughout the city of Montevideo, the university provides an academic platform to more than 80,000 students.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM